These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 230740)

  • 1. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral inhibitors of the immune response in uremia. I. Effect of serum and of the supernatant of spleen cultures from uremic rats on the mixed lymphocyte reaction.
    Raskova J; Morrison AB
    Lab Invest; 1978 Jan; 38(1):103-9. PubMed ID: 146111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral inhibitors of the immune response in uremia. III. The immunosuppressive factor of uremic rat serum is a very low density lipoprotein.
    Raska K; Morrison AB; Raskova J
    Lab Invest; 1980 Jun; 42(6):636-42. PubMed ID: 6446621
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunity and lymphocyte populations in developing uremia in the rat.
    Raskova J; Czerwinski DK; Shea SM; Raska K
    J Exp Pathol; 1986; 2(4):229-45. PubMed ID: 2946817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.
    Levy JG; Smith AG; Whitney RB; McMaster R; Kilburn DG
    Immunology; 1976 Apr; 30(4):565-73. PubMed ID: 131782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients.
    Bourgoignie JJ; Hwang KH; Ipakchi E; Bricker NS
    J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro.
    Raskova J; Raska K
    Lab Invest; 1981 Nov; 45(5):410-7. PubMed ID: 6457930
    [No Abstract]   [Full Text] [Related]  

  • 9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor alveolar macrophages in experimentally induced uremia.
    Alevy YG; Hutcheson P; Mueller KR; Slavin RG
    J Reticuloendothel Soc; 1983 Jan; 33(1):11-20. PubMed ID: 6572723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.
    Raskova J; Raska K
    Am J Pathol; 1983 May; 111(2):149-55. PubMed ID: 6221666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response in experimentally induced uremia. V. Description of a model for chronic uremia in the rat that produces a long-term suppressive effect on T cell responses to mitogens.
    Alevy YG; Mueller KR; Hutcheson P; Slavin RG
    J Lab Clin Med; 1983 May; 101(5):717-25. PubMed ID: 6601172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of immunoregulatory factors from normal human serum. I. Preliminary biochemical and biological characterization of immunosuppressive factors.
    Voorting-Hawking M; Michael JG
    J Immunol; 1977 Feb; 118(2):505-13. PubMed ID: 190315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies on Kawasaki disease: II. Isolation and characterization of an immunosuppressive factor in acute phase sera.
    Hirao J; Yoshimura N; Homma N; Kano K
    Clin Exp Immunol; 1987 Feb; 67(2):433-40. PubMed ID: 3111761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietic inhibitors in uremic serum.
    Freedman MH; Grunberger T; Saunders EF
    Clin Invest Med; 1982; 5(4):237-40. PubMed ID: 7160111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory substances produced by lymphocytes. II. Lymphotoxin in the rat.
    Namba Y; Waksman BH
    J Immunol; 1975 Oct; 115(4):1018-22. PubMed ID: 1080770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).
    Rocklin RE
    J Immunol; 1975 Apr; 114(4):1161-5. PubMed ID: 1090666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in experimentally induced uremia. IV. Characterization of suppressor peritoneal macrophages in the uremic rat.
    Alevy YG; Mueller KR; Slavin RG
    J Lab Clin Med; 1982 Nov; 100(5):735-44. PubMed ID: 7130830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host immune status in uraemia. II. Serum factors and lymphocyte transformation.
    Stewart E; Miller TE
    Clin Exp Immunol; 1980 Jul; 41(1):123-9. PubMed ID: 6969146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein-adsorption from cancer sera--influence on a mixed lymphocyte culture.
    Richner J; Schuff-Werner P; Bätge R; Beyer JH; Nagel GA
    J Clin Lab Immunol; 1985 Oct; 18(2):75-9. PubMed ID: 2934552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.